Sélectionner une page

Daniel DA COSTA

Business Development Manager

Label-free technologies; Clinical Target identification; Clinical mode of action elucidation; Predictive biomarker identification; Patient stratification; Personalized Medicine;Target engagement

Inoviem Scientific is a Contract Research Biotech, whose mission is to help pharmaceutical companies to secure the development of their lead compound by offering cutting-edge technologies that decipher drug mode of action and identify therapeutic targets within their functional interactome. With a “patients-come-first” and a “bed-to-bench” visions, Inoviem Scientific has developed the two state-of-the-art and innovative technologies:
– PIMS® aiming at patients’ stratification for better-personalized therapies.
– NPOT® for the identification of the therapeutic or toxic drug targets within their native interactome. The interest of this disruptive technology is the discovery of the therapeutic targets that will be directly impacted by the drug and the deciphering of drug mode of action to explain therapeutic effects